Therapeutics Today

TT Index

2023

• November
  • Risk of Gastrointestinal Adverse Events Associated with GLP-1 Receptor Agonists for Weight Loss
  • Paediatric ADHD medication errors reported to US poison Centres
  • Managing drugs with anticholinergic activity

• October

  • Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs.
  • Prevalence and predictors of primary non-adherence in primary care
  • Aspirin for secondary prevention of cardiovascular disease

• September

  • Folic acid supplementation to prevent neural tube defects
  • Association between daily step count and all-cause and cardiovascular mortality
  • Cardiac and renal effects of sodium-glucose co-transporter 2 (SGLT2)
• August
  
  • Electrolyte disturbances due to proton pump inhibitors (PPIs)
  • Vaccine hesitancy
  • Familial hypercholesterolaemia (FH)
• July
  
  • COPD exacerbations and pneumonia hospitalisations among new users of combination maintenance inhalers.
  • Health Products Regulatory Authority updates
  • Polypharmacy and cumulative anticholinergic burden in older adults hospitalised with a fall
  • Low-dose aspirin and risk of serious falls and fractures in healthy older people
• June
  
  • Bipolar disorder – monitoring drug interventions
  • Trends in severe outcomes of adults and patients hospitalised with COVID -19
  • Women’s pre-conception health in England
• May
  
  • Medication work among nonagenarians
  • Use of pharmacy services in community-dwelling middle-age and older adults.
  • NMIC useful medicines information resources webpage
  • Oral anticoagulant safety audit
  • Prevalence of antibiotic-associated Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN).
• April
  
  • Breast cancer risk and contraception
  • NMIC CPD module on HSeLanD!
  • Prevention of hospital admissions for adverse drug reactions
  • Withdrawing from SSRI antidepressants
• March
  
  • BRAINS & AIMS
  • Further NMIC learning module on HSeLanD!
  • Reduce unnecessary use of proton pump inhibitors (PPIs)
  • Teachable moment – Paxlovid   avoiding drug-drug interactions
  • Guideline updates
• February
  • Metabolic adverse events associated with systemic corticosteroid therapy
  • Prevalence of drug-drug interactions in older adults in the community
  • Values and preferences of patients and caregivers regarding eczema treatment
  • Online eczema interventions to support self-care for children and young people
  • Updated National Clinical Guidelines in Obstetrics and Gynaecology

• January
  • Adverse drug reactions in older people in the community in Ireland
  • Thinking of a New Year’s resolution
  • Gynaecomastia
  • Glucocorticoid induced adrenal insufficiency (GC-AL)
  • Regular Updates
  • New Feature

2022

• December
  
  • Thank you very much!
  • Morning versus evening antihypertensive medicine
  • Health Products Authority (HPRA) Update
  • Switching from a metered dose inhaler to a dry powder inhaler – effects on climate emissions and asthma control
  • Effectiveness of physical activity interventions delivered or prompted by healthcare professionals in primary care
  • NMIC Therapeutics Today 2022
• November
  
  • The revised isotretinoin pregnancy prevention programme: awareness, knowledge & implementation in practice of healthcare professionals.
  • Risk of co-prescribing non-steroidal anti-inflammatory drugs and oral anticoagulants.
  • Medicines Management Programme updates.
  • Effectiveness of preconception care interventions in primary care.
  • Paxlovid: update on prescribing and access
• October
  
  • ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.
  • HSE-Medicines Management Programme Update
  • Trends in direct oral anticoagulant prescribing in primary care in England
  • Gastrointestinal bleeding risk after concomitant treatment with non-vitamin K oral anticoagulants and oral glucocorticoids.
• September
  • Obesity and oral emergency contraception
  • Recent journal Articles on pregnancy
  • Prescribing trends of antihypertensive medicines in the UK over 31 years
  • Health Products Regulatory Authority updates
  • HSeLanD Learning Module
• August
  
  • Adverse drug reactions, multimorbidity and polypharmacy
  • Information resources for Ukrainian medicines
  • NMIC useful information resources webpage update
  • Medication Safety Minutes
  • Guideline update
• July Supplement
  
  • Paxlovid : Update on prescribing and access
  • Key safety Points
  • Eligibility and prescribing considerations
  • Drug-drug interactions
  • Supply
• July
  
  • Opioids versus non-opioids following surgical discharge
  • Further NMIC learning module on HSeLanD
  • Management of Gout
  • Guidance documents update
• June
  
  • Serotonin Syndrome
  • Intramuscular injections in patients taking anticoagulant
  • Guideline updates
  • Drug reaction with eosinophilia and systemic symptoms (DRESS)
  • Use of medications that may raise blood pressure
• May
  
  • Long-term nitrofurantoin therapy
  • Health Products Regulatory Authority updates
  • Guideline updates
  • Montelukast and neuropsychiatric reactions
  • Dose of paracetamol and low body weight
  • Factors to consider when using medicines following bariatric surgery
• April
  
  • Sodium valproate (Epilim) utilisations trends in Ireland
  • Emollients and risk of burns
  • Non- vitamin K antagonist oral anticoagulants (NOACs) and pharmacokinetic drug interactions
  • Examples of medicines that should be prescribed by brand name
  • Guideline updates
  • NMIC CPD modules on contraception
  • Ukrainian Medicines Information Resources
• March
  • Paxlovid and risk of drug interactions
  • Ireland’s second One Health National Action Plan (iNAP2) on Antimicrobial Resistance 2021-2025
  • Regular Updates
  • Measles
• February
  
  • Overactive bladder (OAB) in women
  • Regular updates
  • Patient adherence, satisfaction and knowledge of direct oral anticoagulants (DOACs)
  • Impact of Gp-delivered medication review of older patients with multimorbidity and polypharmacy

• January
  
  • Associations of Statins adherence and lipid targets with adverse outcomes in patients following myocardial infarction
  • Fatal adverse drug reactions
  • Childhood constipation

2021

• December
  
  • NMIC publications 2021
  • Fruit and Vegetable intake and mortality
  • NMIC Clinical Enquiry Answering Service (CEAS)
  • Thinking about a new year’s resolution
  • Medicines Management Programme – Preferred Drugs
• November
  
  • Gastrointestinal bleeding in older persons using aspirin
  • Domperidone and the risk of suddent cardiac death and ventricular arrhythmias
  • Bariatric Surgery and Oral Medicine Dosing
  • Regular NMCI Updates
• October
  • Medication-related harm
  • Further NMIC learning module on HSeLand
  • Wrong dose medication incidents in a UK hospital
  • Dental implications of some commonly prescribed medicines
  • Regular NMIC updates
• September
  
  • Medication adherence in cardiovascular disease
  • Medicines Management Programme (MMP) Update
  • Further NMIC learning module on HSeLanD!
  • Concurrent use of benzodiazepines and opioids and risk of hospitalisation and death
  • Supplements and risk of drug interactions
  • Regular Updates

• August
  • Gabapentinoid and diuretic prescribing cascade
  • Medication Safety Minutes
  • Healthcare professionals’ awareness of Pregnancy Prevention Programme for sodium valproate (Epilim®) in Ireland
  • Update to Antibiotic Prescribing website
  • Health Products Regulatory Authority Updates
• July
  
  • Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland;
  • NMIC useful medicines information resources webpage update
  • Poisoning related to medication errors with low-dose methotrexate
  • Potentially inappropriate prescribing in people in the community with chronic kidney disease
  • COVID-19 vaccine
    
    
• June: 
  • Use of oral anticoagulants in elderly patients with atrial fibrillation
  • Postural hypotension
  • Recent Medication Safety Minutes
  • Recent Irish College of General Practitioners (ICGP) clinical guide
  • Health Products Regulatory Authority update regarding Vaxzevria®
  • Useful information and resources on COVID-19 vaccinations
    
    
• May: 
  • Trends in strong opioid prescribing in Ireland
  • Pharmacist-led interventions to reduce adverse drug events in older people living in residential care facilities
  • Use of aspirin to prevent pre-eclampsia
  • HPRA Drug Safety Newsletter April 2021
  • Updated Guidelines
  • Further NMIC learning module on HSeLanD!
• April: 
  • Drug-related deaths in European Hospitals
  • Comparison of interventions for reducing symptoms of depression in people with dementia
  • Bisphosphonate holidays
  • Recent Irish College of General Practitioners (ICGP) clinical guides
  • Reminder about CPD modules
  • Useful information and resources on COVID-19 vaccinations
• March: 
  • Potentially inappropriate prescribing (PIP) in middle-aged adults
  • Medicines Management Programme (MMP) updates
  • Health Products Regulatory Authority (HPRA) Drug Safety Newsletter
  • Interventions in an ambulatory setting to prevent progression to severe disease in patients with COVID-19
  • Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain
  • Prescribing and sustainability - Irish Doctors for the Environment (IDE)
  • Useful information and resources on COVID-19 vaccines
  • NMIC bulletin on direct oral anticoagulants
  • Recent Irish College of General Practitioners (ICGP) clinical guide
• February: 
  • Ten helpful hints to increase pharmacotherapy safety
  • Medicines Management Programme (MMP) Updates
  • Useful Information and Resources on COVID-19 vaccinations
  • Sodium-glucose contransporter protein-2 inhibitors (SGLT-2i) and glucagon-like peptide-1 receptor agonists (GLP-1ra) for type 2 diabetes
  • Two NMIC learning modules on Drug Interactions are on HSELanD!
    
    
• January: 
  • Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke
  • HPRA Drug Safety newsletter 100th Edition!
  • Contraceptive use and fertility
  • Use of Z-drugs in people living with dementia
  • Resources available on COVID-19 vaccine